Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-02-26 @ 6:28 AM
Study NCT ID:
NCT04846959
Status:
RECRUITING
Last Update Posted:
2025-07-17
First Post:
2021-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for … | View |